Large $400M Capital RaiseThe $400M registered direct offering materially strengthens liquidity to fund manufacturing expansion, targeted acquisitions, R&D and working capital. This reduces execution and financing risk during scale-up and provides multi‑quarter runway to invest in wafer‑level production and commercialization.
Lumilens Strategic Supply DealA structured supply and co‑development agreement with Lumilens creates multi‑year revenue visibility and aligns POET with a partner capable of wafer‑scale production. This supports volume economics, qualification roadmaps, and market access needed to scale for hyperscaler AI and data‑center deployments.
Experienced COO HiredAppointing an 18‑plus year semiconductor operations leader to run manufacturing increases execution capability for high‑volume production. Strong operational leadership improves manufacturability, supply chain setup and process qualifications, reducing execution risk as the company shifts from R&D to product scale.